Novel drug molecule could help treat Parkinson’s disease in young patients

More than 100,000 Canadians currently live with Parkinson’s disease. A novel drug molecule being studied by researchers from McGill University could reactivate housekeeping functions in brain cells of young Parkinson’s patients, paving the way for potential future treatments for this incurable, degenerative disease.

This post was originally published on this site

Skip The Dishes Referral Code

KeyLegal.ca - Consult a Lawyer Online in a variety of legal subjects